NextGen and Cytomyx to Develop Protein Biochips for Cancer | GenomeWeb

NEW YORK, Jan. 16 - NextGen Sciences, Cytomyx, and a University of Cambridge cancer researcher have struck a collaboration to identify proteins involved in the progress of breast cancer and potentially use data from the process to develop new protein biochips.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.